Literature DB >> 5082554

Dangers of diazoxide.

M S Knapp, R Cove-Smith, G Hall, M McIllmurray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5082554      PMCID： PMC1786475          DOI： 10.1136/bmj.4.5834.229-b

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Controlled studies in clinical cancer research.

Authors:  T C Chalmers; J B Block; S Lee
Journal:  N Engl J Med       Date:  1972-07-13       Impact factor: 91.245

2.  Effects of fetal exposure to diazoxide in man.

Authors:  R D Milner; S K Chouksey
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

3.  Severe non-ketotic hyperglycaemic pre-coma in a hypertensive patient receiving diazoxide.

Authors:  B D Harrison; T W Rutter; R T Taylor
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

4.  When should randomisation begin?

Authors:  T C Chalmers
Journal:  Lancet       Date:  1968-04-20       Impact factor: 79.321

5.  The use of diazoxide in hypertensive crises with particular reference to the control of hypertension in severe renal failure.

Authors:  T H Mathew; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.

Authors:  J E Pohl; H Thurston; D Davis; M Y Morgan
Journal:  Br Med J       Date:  1972-06-03

7.  Use of diazoxide in hypertension with renal failure.

Authors:  J E Pohl; H Thurston
Journal:  Br Med J       Date:  1971-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.